Impact of diabetes on long term follow-up of elderly patients with chronic total occlusion post percutaneous coronary intervention

Journal of Geriatric Cardiology

Volumn 10, Issue 1, 2013, Pages 16-20

  Liu, Wei ^a   Wagatsuma, Kenji ^b   Nii, Hideo ^b   Toda, Mikihito ^b   Amano, Hideo ^b   Uchida, Yasuto ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b TOHO UNIVERSITY   (Japan)

Author keywords

Chronic total occlusion; Diabetes; Drug eluting stent; Elderly patient; Percutaneous coronary intervention

Indexed keywords

HEMOGLOBIN A1C; PACLITAXEL; RAPAMYCIN;

AGED; ARTICLE; BARE METAL STENT; CHRONIC DISEASE; CHRONIC TOTAL OCCLUSION; CONTROLLED STUDY; DEATH; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; FOLLOW UP; GERIATRIC PATIENT; HEART DISEASE; HEART INFARCTION; HUMAN; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE; REVASCULARIZATION;

EID: 84878963324     PISSN: 16715411     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1671-5411.2013.01.004     Document Type: Article

References (17)

1. Stone GW, Reifart NJ, Moussa I, et al. Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part II. Circulation 2005; 112: 2530-2537. (Pubitemid 41504504)
2. Stone GW, Kandzari DE, Mehran R, et al. Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part I. Circulation 2005; 112: 2364-2372. (Pubitemid 41464580)
3. Aziz S, Stables RH, Grayson AD, et al. Percutaneous coronary intervention for chronic total occlusions: improved survival for patients with successful revascularization compared to a failed procedure. Catheter Cardiovasc Interv 2007; 70: 15-20. (Pubitemid 47035987)
4. Han YL, Zhang J, Li Y, et al. Long-term outcomes of drug-eluting versus bare-metal stent implantation in patients with chronic total coronary artery occlusions. Chin Med J 2009; 122: 643-647.
5. De Felice F, Fiorilli R, Parma A, et al. 3-year clinical outcome of patients with chronic total occlusion treated with drug-eluting stents. JACC Cardiovasc Interv 2009, 2: 1260-1265
6. Migliorini A, Moschi G, Vergara R, et al. Drug-eluting stent-supported percutaneous coronary intervention for chronic total coronary occlusion. Catheter Cardiovasc Interv 2006; 67: 344-348. (Pubitemid 43346730)
7. Hoye A, Tanabe K, Lemos PA, et al. Significant reduction in restenosis after the use of sirolimus-eluting stents in the treatment of chronic total occlusions. J Am Coll Cardiol 2004; 43: 1954-1958. (Pubitemid 38686787)
8. Patel MR, Marso SP, Dai D, et al. Comparative effectiveness of drug-eluting versus bare-metal stents in elderly patients undergoing revascularization of chronic total coronary occlusions: results from the national cardiovascular data registry, 2005-2008. JACC Cardiovasc Interv 2012; 5: 1054-1061.
9. Kugelmass AD, Cohen DJ, Houser F, et al. The influence of diabetes mellitus on the practice and outcomes of percutaneous coronary intervention in the community: a report from the HCA database. J Invasive Cardiol 2003; 15: 568-574. (Pubitemid 37288541)
10. Claessen BE, Dangas GD, Godino C, et al. Long-term clinical outcomes of percutaneous coronary intervention for chronic total occlusions in patients with versus without diabetes mellitus. Am J Cardiol 2011; 108: 924-931.
11. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2012; 2013; 36 ( Suppl 1): S67-S74.
12. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39 ( 2 Suppl 1): S1-S266.
13. Lee SP, Kim SY, Park KW, et al. Long-term clinical outcome of chronic total occlusive lesions treated with drug-eluting stents: comparison of sirolimus-eluting and paclitaxel-eluting stents. Circ J 2010; 74: 693-700.
14. De Felice F, Fiorilli R, Parma A, et al. Outcome of diabetic and non-diabetic patients undergoing successful coronary angioplasty with bare stent of chronic total occlusion. J Cardiovasc Med (Hagerstown) 2006; 7: 847-851. (Pubitemid 44813710)
15. Ueda H, Mitsusada N, Harimoto K, et al. Glycosylated hemoglobin is a predictor of major adverse cardiac events after drug-eluting stent implantation in patients with diabetes mellitus. Cardiology 2010; 116: 51-57.
16. Kornowski R, Fort S, Almagor Y, et al. Impact of vessel size, lesion length and diabetes mellitus on angiographic restenosis outcomes: insights from the NIRTOP study. Acute Card Care 2008; 10: 104-110. (Pubitemid 351883445)
17. Ledru F, Ducimetiere P, Battaglia S, et al. New diagnostic criteria for diabetes and coronary artery disease: insights from an angiographic study. J Am Coll Cardiol 2001; 37: 1543-1550.